| Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study HU Ahmed, AES Bosaily, LC Brown, R Gabe, R Kaplan, MK Parmar, ... The Lancet 389 (10071), 815-822, 2017 | 3084 | 2017 |
| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2838 | 2018 |
| EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction M Oelke, A Bachmann, A Descazeaud, M Emberton, S Gravas, MC Michel, ... European urology 64 (1), 118-140, 2013 | 1464 | 2013 |
| Systematic review of complications of prostate biopsy S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton, R Nam, ... European urology 64 (6), 876-892, 2013 | 1196 | 2013 |
| Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ... European urology 68 (6), 1045-1053, 2015 | 890 | 2015 |
| Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ... European urology 59 (4), 477-494, 2011 | 888 | 2011 |
| EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines) S Madersbacher, G Alivizatos, J Nordling, CR Sanz, M Emberton, ... European urology 46 (5), 547-554, 2004 | 888 | 2004 |
| Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review CM Moore, NL Robertson, N Arsanious, T Middleton, A Villers, L Klotz, ... European urology 63 (1), 125-140, 2013 | 679 | 2013 |
| Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review M Valerio, I Donaldson, M Emberton, B Ehdaie, BA Hadaschik, LS Marks, ... European urology 68 (1), 8-19, 2015 | 528 | 2015 |
| Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013 | 468 | 2013 |
| EAU Guidelines on benign prostatic hyperplasia (BPH) JJ de la Rosette, G Alivizatos, S Madersbacher, M Perachino, D Thomas, ... European urology 40 (3), 256-263, 2001 | 448 | 2001 |
| Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study HU Ahmed, RG Hindley, L Dickinson, A Freeman, AP Kirkham, M Sahu, ... The lancet oncology 13 (6), 622-632, 2012 | 447 | 2012 |
| How good is MRI at detecting and characterising cancer within the prostate? APS Kirkham, M Emberton, C Allen European urology 50 (6), 1163-1175, 2006 | 445 | 2006 |
| Early detection of cancer D Crosby, S Bhatia, KM Brindle, LM Coussens, C Dive, M Emberton, ... Science 375 (6586), eaay9040, 2022 | 431 | 2022 |
| Weakly-supervised convolutional neural networks for multimodal image registration Y Hu, M Modat, E Gibson, W Li, N Ghavami, E Bonmati, G Wang, ... Medical image analysis 49, 1-13, 2018 | 428 | 2018 |
| The role of focal therapy in the management of localised prostate cancer: a systematic review M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ... European urology 66 (4), 732-751, 2014 | 428 | 2014 |
| Photodynamic therapy for prostate cancer—a review of current status and future promise CM Moore, D Pendse, M Emberton Nature clinical practice Urology 6 (1), 18-30, 2009 | 392 | 2009 |
| Benign prostatic hyperplasia: a progressive disease of aging men1 M Emberton, GL Andriole, J De La Rosette, B Djavan, K Hoefner, ... Urology 61 (2), 267-273, 2003 | 389 | 2003 |
| Is it time to consider a role for MRI before prostate biopsy? HU Ahmed, A Kirkham, M Arya, R Illing, A Freeman, C Allen, M Emberton Nature reviews Clinical oncology 6 (4), 197-206, 2009 | 381 | 2009 |
| Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised … AR Azzouzi, S Vincendeau, E Barret, A Cicco, F Kleinclauss, ... The Lancet Oncology 18 (2), 181-191, 2017 | 342 | 2017 |
Professor Hashim U AhmedProfessor and Chair, Imperial Urology, Imperial College London在 imperial.ac.uk 的电子邮件经过验证
